Anti-HMGCR myopathy: observed ethnic differences in disease and disease outcomes in New Zealand
In addition to having higher incidence of anti-HMGCR myopathy, Polynesians are affected at a younger age and are less likely to achieve normal CK levels despite treatment over similar follow-up periods. The disproportionate burden of disease in this group should prompt early assessment of a Polynesian patient who presents with muscle symptoms while on a statin.
Authors
- J O'donnell (ORCID: https://orcid.org/0000-0002-3425-4805)
- Ke Li Chow (ORCID: https://orcid.org/0000-0002-4589-0735)
- Hamish Anderson (ORCID: https://orcid.org/0009-0005-2014-1446)
Institutions
- John Hunter Hospital (AU)
- Canterbury Health Laboratories (NZ)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-06-12
- DOI
- https://doi.org/10.1093/rheumatology/keaf338
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00